文献速递神经肿瘤

溶瘤寨卡病毒借CCR2+单核细胞增强抗胶质母细胞瘤T细胞反应

Oncolytic zika virus therapy leverages CCR2+ monocytes to boost anti-glioblastoma T cell responses.
PubMed 文献 · Neuro Oncol · 2026-01-01

该研究探讨溶瘤寨卡病毒(ZIKV)治疗胶质母细胞瘤(GBM)时如何通过单核细胞驱动疗效。采用单细胞RNA测序和TCR测序评估ZIKV治疗后CD8+ T细胞反应,并用同系免疫活性小鼠GBM模型验证机制。发现ZIKV诱导肿瘤浸润CD8+ T细胞克隆扩增且富集颗粒酶B和穿孔素-1、减少耗竭标志物,CCR2+单核细胞对CD8+ T细胞招募、增殖和效应功能至关重要,干扰单核细胞运输或功能则削弱这些反应。

要点

  • ZIKV治疗诱导GBM内CD8+ T细胞克隆扩增并增强细胞毒性、减少耗竭。
  • CCR2+单核细胞是ZIKV驱动抗肿瘤CD8+ T细胞招募和效应功能的关键。
  • 干扰CCR2+单核细胞运输或功能会削弱T细胞招募和细胞毒性活性。

核心结论

  • ZIKV驱动CCR2+单核细胞激活和招募,通过增强细胞毒性和限制耗竭支持强效抗肿瘤CD8+ T细胞反应。
  • 调节单核细胞-T细胞交互作用具有克服GBM免疫抑制的治疗潜力。

研究设计与样本

  • 采用单细胞RNA测序和T细胞受体(TCR)测序评估ZIKV治疗后CD8+ T细胞反应。
  • 使用CellChat定义ZIKV激活的CCR2+单核细胞与CD8+ T细胞间信号网络。
  • 采用同系免疫活性小鼠GBM模型,通过遗传和抗体方法损害CCR2+单核细胞运输和功能以验证机制。

主要发现

  • ZIKV诱导肿瘤浸润CD8+ T细胞克隆扩增,富集颗粒酶B和穿孔素-1,耗竭标志物表达降低。
  • CCR2+单核细胞对肿瘤微环境中抗肿瘤CD8+ T细胞的招募、增殖和效应功能必不可少。
  • 破坏单核细胞运输或功能会损害上述反应,减弱细胞毒性活性和T细胞招募。

临床怎么用

  • ZIKV治疗GBM的疗效可能依赖于CCR2+单核细胞介导的T细胞反应,提示监测单核细胞功能或为评估疗效的潜在方向。
  • 靶向单核细胞-T细胞交互作用可能成为增强GBM免疫治疗的新策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Glioblastoma (GBM) is a lethal brain tumor with limited treatment options, largely due to profound immune suppression within the tumor microenvironment (TME), the failure of current immunotherapies to restore CD8+ T cell function, and persistence of glioma stem cells (GSCs) after treatment. Oncolytic Zika virus (ZIKV) is a promising therapeutic that selectively targets GSCs and remodels the TME to enhance anti-tumor CD8+ T cell responses. In this study we investigated how ZIKV efficacy in GBM is driven through monocytes. METHODS: We performed single-cell RNA sequencing and T cell receptor (TCR) sequencing to evaluate CD8+ T cell responses following ZIKV treatment. We used CellChat to define signaling networks between ZIKV-activated CCR2+ monocytes and CD8+ T cells in the TME. We used syngeneic, immunocompetent murine GBM models to validate mechanisms in vivo, applying genetic and antibody-based approaches to impair CCR2+ monocyte trafficking and function. RESULTS: ZIKV-induced clonal expansion of tumor-infiltrating CD8+ T cells enriched in granzyme B and perforin-1, with reduced expression of exhaustion markers. CCR2+ monocytes were essential for the recruitment, proliferation, and effector functions of anti-tumor CD8+ T cells in the TME. Disruption of monocyte trafficking or function impaired these responses, diminishing cytotoxic activity and T cell recruitment. CONCLUSIONS: ZIKV-driven activation and recruitment of CCR2+ monocytes supports robust anti-tumor CD8+ T cell responses by enhancing cytotoxicity and limiting exhaustion. These findings highlight the previously unappreciated therapeutic potential of modulating monocyte-T cell crosstalk to overcome immune suppression in GBM.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Cashman KS, Mistry AM, Kesarwani A, et al. Oncolytic zika virus therapy leverages CCR2+ monocytes to boost anti-glioblastoma T cell responses. Neuro Oncol. 2026. PMID: 41729934. doi:10.1093/neuonc/noag037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。